Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 752 All time
- Disclosed funding
- $25.4B 616 disclosed amounts
- Median round
- $15.8M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| B Develops wearable EEG technology for cognitive performance improvement | €650K | Pre-SeedPre-seed | Healthtech | Sweden | Investors | |
| MM Develops medical devices for women's pelvic health | $5M | Series B | Healthtech | United States | Investors | |
| Q Builds fully autonomous robotic pharmacy for prescription fulfillment | $12.6M | Seed | Healthtech | United States | Investors | |
| XB Xellar BiosystemsCompany profile Develops 3D human tissue models for drug discovery and testing using Organ-on-a-Chip technology Develops 3D human tissue models for drug discovery and testing using Organ-on-a-Chip technology | $50M | Series A | Healthtech, Biotech | United States | Investors Undisclosed | |
| A AlanCompany profile Alan combines health insurance, preventive services and access to care in a digital platform for employers and members. Alan combines health insurance, preventive services and access to care in a digital platform for employers and members. | €480M | Series GSeries C+ | Healthtech, Fintech | France | Investors | |
| LL Leyden LaboratoriesCompany profile Develops antibody-based nasal sprays intended to prevent influenza and other respiratory-virus infections. Develops antibody-based nasal sprays intended to prevent influenza and other respiratory-virus infections. | €40M | Series B | Healthtech, Biotech | Netherlands | Investors | |
| T TissiumCompany profile Develops biomorphic programmable polymers that repair nerves and tissue without stitches Develops biomorphic programmable polymers that repair nerves and tissue without stitches | €30M | Series D+Series C+ | Healthtech | France | Investors | |
| x Transforms fragmented medical records into decision-ready data | $46M | Series B | Healthtech | United States | Investors | |
| AH Assort HealthCompany profile Provides AI-powered patient journey platform for healthcare organizations Provides AI-powered patient journey platform for healthcare organizations | $120M | Series CSeries C+ | Healthtech | United States | Investors | |
| OB Ollin BiosciencesCompany profile Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD | $330M | Series B | Healthtech, Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →